InProTher is an immuno therapy company dedicated to developing the world’s first adaptive immune therapy.
InProTher has raised $6.5M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
InProTher's investors include European Innovation Council, SeedFolio.
InProTher is headquartered in Copenhagen, Denmark.
InProTher is an immuno therapy company dedicated to developing the world’s first adaptive immune therapy.
InProTher is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InProTher — Funding & Investors." VCBacked, May 24, 2023, https://www.vcbacked.co/company/inprother. Accessed October 19, 2026.
VCBacked. (2023). InProTher — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/inprother
{{cite web |title=InProTher — Funding & Investors |url=https://www.vcbacked.co/company/inprother |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated